Irbesartan: Difference between revisions
From SEHK Wiki
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
!style="text-align: left"| Legal Classification: | !style="text-align: left"| Legal Classification: | ||
|P1S1S3 | |P1S1S3 | ||
|} | |||
==Drug Names== | |||
{| class="wikitable" | |||
!Generic Name 藥物化學名稱 | |||
!HA Code 藥物代碼 | |||
!Legal Classification法律藥物分類 | |||
!Brand Name 藥名 | |||
|- | |||
| Irbesartan Tablet 150mg | |||
| IRBE01 | |||
| P1S1S3 | |||
| rowspan="2" | APROVEL TABLET | |||
C0APROVEL TAB 150/12.5MG (irbesartan 150mg + hydrochlorothiazide 12.5mg) | |||
C0APROVEL TAB 300/12.5MG (irbesartan 300mg + hydrochlorothiazide 12.5mg) | |||
|- | |||
| Irbesartan Tablet 300mg | |||
| IRBE02 | |||
| P1S1S3 | |||
|} | |} | ||
Revision as of 22:08, 23 August 2022
Irbesartan (中文:厄貝沙坦) is an angiotensin receptor blocker.
Pronunciation
Irbesartan 150mg (APROVEL 150mg)
| Generic Name: | Irbesartan |
|---|---|
| Class: | Cardiovascular Drug |
| Subclass: | angiotensin receptor blocker |
| Legal Classification: | P1S1S3 |
Drug Names
| Generic Name 藥物化學名稱 | HA Code 藥物代碼 | Legal Classification法律藥物分類 | Brand Name 藥名 |
|---|---|---|---|
| Irbesartan Tablet 150mg | IRBE01 | P1S1S3 | APROVEL TABLET
C0APROVEL TAB 150/12.5MG (irbesartan 150mg + hydrochlorothiazide 12.5mg) C0APROVEL TAB 300/12.5MG (irbesartan 300mg + hydrochlorothiazide 12.5mg) |
| Irbesartan Tablet 300mg | IRBE02 | P1S1S3 |
